These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 34795215)

  • 41. Eradication of acute promyelocytic leukemia-initiating cells through PML-RARA degradation.
    Nasr R; Guillemin MC; Ferhi O; Soilihi H; Peres L; Berthier C; Rousselot P; Robledo-Sarmiento M; Lallemand-Breitenbach V; Gourmel B; Vitoux D; Pandolfi PP; Rochette-Egly C; Zhu J; de Thé H
    Nat Med; 2008 Dec; 14(12):1333-42. PubMed ID: 19029980
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Frat2 mediates the oncogenic activation of Rac by MLL fusions.
    Walf-Vorderwülbecke V; de Boer J; Horton SJ; van Amerongen R; Proost N; Berns A; Williams O
    Blood; 2012 Dec; 120(24):4819-28. PubMed ID: 23074275
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Identification of KIF5B-RET and GOPC-ROS1 fusions in lung adenocarcinomas through a comprehensive mRNA-based screen for tyrosine kinase fusions.
    Suehara Y; Arcila M; Wang L; Hasanovic A; Ang D; Ito T; Kimura Y; Drilon A; Guha U; Rusch V; Kris MG; Zakowski MF; Rizvi N; Khanin R; Ladanyi M
    Clin Cancer Res; 2012 Dec; 18(24):6599-608. PubMed ID: 23052255
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pot1 OB-fold mutations unleash telomere instability to initiate tumorigenesis.
    Gu P; Wang Y; Bisht KK; Wu L; Kukova L; Smith EM; Xiao Y; Bailey SM; Lei M; Nandakumar J; Chang S
    Oncogene; 2017 Apr; 36(14):1939-1951. PubMed ID: 27869160
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Druggable oncogene fusions in invasive mucinous lung adenocarcinoma.
    Nakaoku T; Tsuta K; Ichikawa H; Shiraishi K; Sakamoto H; Enari M; Furuta K; Shimada Y; Ogiwara H; Watanabe S; Nokihara H; Yasuda K; Hiramoto M; Nammo T; Ishigame T; Schetter AJ; Okayama H; Harris CC; Kim YH; Mishima M; Yokota J; Yoshida T; Kohno T
    Clin Cancer Res; 2014 Jun; 20(12):3087-93. PubMed ID: 24727320
    [TBL] [Abstract][Full Text] [Related]  

  • 46. YAP1 and its fusion proteins in cancer initiation, progression and therapeutic resistance.
    Szulzewsky F; Holland EC; Vasioukhin V
    Dev Biol; 2021 Jul; 475():205-221. PubMed ID: 33428889
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Landscape of Acquired Resistance to Osimertinib in
    Piotrowska Z; Isozaki H; Lennerz JK; Gainor JF; Lennes IT; Zhu VW; Marcoux N; Banwait MK; Digumarthy SR; Su W; Yoda S; Riley AK; Nangia V; Lin JJ; Nagy RJ; Lanman RB; Dias-Santagata D; Mino-Kenudson M; Iafrate AJ; Heist RS; Shaw AT; Evans EK; Clifford C; Ou SI; Wolf B; Hata AN; Sequist LV
    Cancer Discov; 2018 Dec; 8(12):1529-1539. PubMed ID: 30257958
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Novel targets in non-small cell lung cancer: ROS1 and RET fusions.
    Gainor JF; Shaw AT
    Oncologist; 2013; 18(7):865-75. PubMed ID: 23814043
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A Performance Comparison of Commonly Used Assays to Detect RET Fusions.
    Yang SR; Aypar U; Rosen EY; Mata DA; Benayed R; Mullaney K; Jayakumaran G; Zhang Y; Frosina D; Drilon A; Ladanyi M; Jungbluth AA; Rekhtman N; Hechtman JF
    Clin Cancer Res; 2021 Mar; 27(5):1316-1328. PubMed ID: 33272981
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Oncogenic properties and signaling basis of the PAX8-GLIS3 fusion gene.
    Basili T; Dopeso H; Kim SH; Ferrando L; Pareja F; Da Cruz Paula A; da Silva EM; Stylianou A; Maroldi A; Marchiò C; Rubin BP; Papotti M; Weigelt B; Moreira Ferreira CG; Lapa E Silva JR; Reis-Filho JS
    Int J Cancer; 2020 Oct; 147(8):2253-2264. PubMed ID: 32383186
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The landscape of long noncoding RNA-involved and tumor-specific fusions across various cancers.
    Guo M; Xiao ZD; Dai Z; Zhu L; Lei H; Diao LT; Xiong Y
    Nucleic Acids Res; 2020 Dec; 48(22):12618-12631. PubMed ID: 33275145
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Oncogenic cooperation between TCF7-SPI1 and NRAS(G12D) requires β-catenin activity to drive T-cell acute lymphoblastic leukemia.
    Van Thillo Q; De Bie J; Seneviratne JA; Demeyer S; Omari S; Balachandran A; Zhai V; Tam WL; Sweron B; Geerdens E; Gielen O; Provost S; Segers H; Boeckx N; Marshall GM; Cheung BB; Isobe K; Kato I; Takita J; Amos TG; Deveson IW; McCalmont H; Lock RB; Oxley EP; Garwood MM; Dickins RA; Uyttebroeck A; Carter DR; Cools J; de Bock CE
    Nat Commun; 2021 Jul; 12(1):4164. PubMed ID: 34230493
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The deubiquitinating enzyme USP37 regulates the oncogenic fusion protein PLZF/RARA stability.
    Yang WC; Shih HM
    Oncogene; 2013 Oct; 32(43):5167-75. PubMed ID: 23208507
    [TBL] [Abstract][Full Text] [Related]  

  • 54. RNA-seq of 272 gliomas revealed a novel, recurrent PTPRZ1-MET fusion transcript in secondary glioblastomas.
    Bao ZS; Chen HM; Yang MY; Zhang CB; Yu K; Ye WL; Hu BQ; Yan W; Zhang W; Akers J; Ramakrishnan V; Li J; Carter B; Liu YW; Hu HM; Wang Z; Li MY; Yao K; Qiu XG; Kang CS; You YP; Fan XL; Song WS; Li RQ; Su XD; Chen CC; Jiang T
    Genome Res; 2014 Nov; 24(11):1765-73. PubMed ID: 25135958
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ubiquitin-Specific Protease 29 Regulates Cdc25A-Mediated Tumorigenesis.
    Chandrasekaran AP; Woo SH; Sarodaya N; Rhie BH; Tyagi A; Das S; Suresh B; Ko NR; Oh SJ; Kim KS; Ramakrishna S
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071237
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Reciprocal products of chromosomal translocations in human cancer pathogenesis: key players or innocent bystanders?
    Rego EM; Pandolfi PP
    Trends Mol Med; 2002 Aug; 8(8):396-405. PubMed ID: 12127726
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tumor Suppressors Having Oncogenic Functions: The Double Agents.
    Datta N; Chakraborty S; Basu M; Ghosh MK
    Cells; 2020 Dec; 10(1):. PubMed ID: 33396222
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identification of recurrent fusion genes across multiple cancer types.
    Yu YP; Liu P; Nelson J; Hamilton RL; Bhargava R; Michalopoulos G; Chen Q; Zhang J; Ma D; Pennathur A; Luketich J; Nalesnik M; Tseng G; Luo JH
    Sci Rep; 2019 Jan; 9(1):1074. PubMed ID: 30705370
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Fusion genes in solid tumors.
    Aman P
    Semin Cancer Biol; 1999 Aug; 9(4):303-18. PubMed ID: 10448117
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Oncogenic Effect of the Novel Fusion Gene
    Yoon D; Bae K; Kim JH; Choi YK; Yoon KA
    Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31083279
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.